Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?

By Zöller Margot  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 659-676

Springer Publishing Company

Access to resources Recommend Favorite

Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells

By Weiss Lola   Or Reuven   Slavin Shimon   Naparstek Ella   Reich Shoshana   Abdul-Hai Ali  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 4, 2004-04 ,pp. : 358-362

Springer Publishing Company

Access to resources Recommend Favorite

Haploidentical, non-myeloablative stem-cell transplantation for advanced renal-cell carcinoma

By Satoh M.   Miyamura K.   Yamada M.   Ishidoya S.   Childs R.W.   Arai Y.  

Lancet Oncology, Vol. 5, Iss. 2, 2004-02 ,pp. : 125-126

Elsevier

Access to resources Recommend Favorite

Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia

By Hebenstreit Karin   Iacobelli Simona   Leiblein Sabine   Eisfeld Ann-Kathrin   Pfrepper Christian   Heyn Simone   Vucinic Vladan   Franke Georg-Nikolaus   Krahl Rainer   Fricke Stephan   Becker Cornelia   Pönisch Wolfram   Behre Gerhard   Niederwieser Dietger   Lange Thoralf  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1274-1280

Informa Healthcare

Access to resources Recommend Favorite

Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant

By Bašić Kinda Sandra  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1334-1335

Informa Healthcare

Access to resources Recommend Favorite